| A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Followin | Phase III | rekrutiert |
| A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F) | Phase I / Phase II | rekrutiert |
| A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorub | Phase II | rekrutiert |
| A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients | Phase III | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially B | Phase I / Phase II | rekrutiert |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Co | Phase II / Phase III | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatie | ohne Phasenangabe | rekrutiert |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibros | Phase III | rekrutiert |
| A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head | Phase III | rekrutiert |
| A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradi | Phase III | rekrutiert |
| A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Ge | Phase II | rekrutiert |
| A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis | Phase II | rekrutiert |
| A Multicenter, Multinational, Cohort Long-term Post-market Clinical Follow-up (PMCF) of the Safe | ohne Phasenangabe | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treat | Phase III | rekrutiert |
| A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo | Phase III | rekrutiert |
| A Phase I Dose Finding Study of MB-CART2219.1 | Phase I | rekrutiert |
| A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestra | Phase II | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD | Phase I / Phase II | rekrutiert |
| A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multi | Phase III | rekrutiert |
| A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs | Phase III | rekrutiert |
| A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH) | Phase II / Phase III | rekrutiert |
| A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) | Phase II | rekrutiert |
| A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiop | Phase III | rekrutiert |
| A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adol | Phase I / Phase II | rekrutiert |
| A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in P | Phase III | rekrutiert |
| A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulc | Phase II | rekrutiert |
| A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults | Phase II | rekrutiert |
| A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal S | Phase III | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous N | Phase II | rekrutiert |
| A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and | Phase III | rekrutiert |
| A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tum | Phase I / Phase II | rekrutiert |
| A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of E | Phase II / Phase III | rekrutiert |
| A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory M | — | rekrutiert |
| A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease | Phase III | rekrutiert |
| A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab | Phase III | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of | Phase II / Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRI | Phase II | rekrutiert |
| A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Int | Phase II / Phase III | rekrutiert |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Particip | Phase II | rekrutiert |
| A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PA | Phase II | rekrutiert |
| A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclero | Phase II | rekrutiert |
| A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spas | Phase I / Phase II | rekrutiert |
| A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemothe | Phase II / Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of The | Phase III | rekrutiert |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients W | Phase II | rekrutiert |
| A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bort | Phase III | rekrutiert |
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | Phase III | rekrutiert |
| A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abe | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Mo | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experience | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sc | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy | Phase III | rekrutiert |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as | Phase II | rekrutiert |
| A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With | Phase II | rekrutiert |
| A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis | Phase II | rekrutiert |
| A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adul | Phase III | rekrutiert |
| A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotocl | Phase III | rekrutiert |
| A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in | Phase I / Phase II | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injec | Phase III | rekrutiert |
| A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis i | Phase II | rekrutiert |
| A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and S | Phase I | rekrutiert |
| A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomi | Phase III | rekrutiert |
| A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resista | Phase III | rekrutiert |
| A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Stan | Phase III | rekrutiert |
| A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Th | Phase III | rekrutiert |
| A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With | — | rekrutiert |
| A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in t | Phase I | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis | Phase III | rekrutiert |
| A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosu | Phase III | rekrutiert |
| A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, P | Phase I | rekrutiert |
| A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD | Phase II | rekrutiert |
| A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma | Phase II / Phase III | rekrutiert |
| A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticos | Phase III | rekrutiert |
| A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalid | Phase III | rekrutiert |
| AI-Based Real-Time Detection of Surgical Smoke Using Endoscopic Data | — | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple My | Phase I / Phase II | rekrutiert |
| AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate | Phase III | rekrutiert |
| AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platin | Phase III | rekrutiert |
| Abbott DBS Post-Market Study of Outcomes for Indications Over Time | — | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Mode | Phase III | rekrutiert |
| An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) | — | rekrutiert |
| An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Stud | Phase III | rekrutiert |
| An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in | Phase III | rekrutiert |
| Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms | — | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Anesthesia Induced Myocardial Injury in Non-cardiac Surgery (AIMY) | — | rekrutiert |
| Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer | Phase I | rekrutiert |
| Argon Plasma Treatment for Ovarian Endometrioma Compared to Standard Cystectomy | ohne Phasenangabe | rekrutiert |
| Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolesce | — | rekrutiert |
| Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | Phase III | rekrutiert |
| Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting | ohne Phasenangabe | rekrutiert |
| Atypical Hemolytic-Uremic Syndrome (aHUS) Registry | — | rekrutiert |
| Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseContr | ohne Phasenangabe | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular | ohne Phasenangabe | rekrutiert |
| Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Ti | ohne Phasenangabe | rekrutiert |
| Brain Signal Training to Enhance Affect Down-regulation | Phase I / Phase II | rekrutiert |
| Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke | ohne Phasenangabe | rekrutiert |
| CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer | — | rekrutiert |
| CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT | Phase I / Phase II | rekrutiert |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer | — | rekrutiert |
| CeraFlex PFO Closure System PMCF Study | — | rekrutiert |
| Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Ad | Phase III | rekrutiert |
| Clinical Course Of Disease In Participants With FA-CM | — | rekrutiert |
| Colorectal Resections in Patients With Retroperitoneal Sarcoma | — | rekrutiert |
| Combination Salvage Therapy With Venetoclax and Decitabine in Relapsed/Refractory AML | Phase II | rekrutiert |
| Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Loca | Phase IV | rekrutiert |
| Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCD | Phase II | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to C | Phase III | rekrutiert |
| DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis | ohne Phasenangabe | rekrutiert |
| DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Pl | Phase II | rekrutiert |
| DEfeating PEnile CAncer-2 | ohne Phasenangabe | rekrutiert |
| De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcino | ohne Phasenangabe | rekrutiert |
| Dexamethasone Eluting Cochlear Implant: a Pivotal Study | ohne Phasenangabe | rekrutiert |
| Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial | — | rekrutiert |
| Dominantly Inherited Alzheimer Network (DIAN) | — | rekrutiert |
| E-health-supported Diagnostic and Intervention in Preterm Born Children and Their Families | ohne Phasenangabe | rekrutiert |
| EASY Algorithm Trial (Elbow Trauma Assessment Using Sonography in Children and Youth) Diagnostic | — | rekrutiert |
| Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke | ohne Phasenangabe | rekrutiert |
| Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody | Phase III | rekrutiert |
| Early Versus Late Initiation of ECMO (Extracorporal Membrane Oxygenation) Trial (ELIEO-Trial) | ohne Phasenangabe | rekrutiert |
| Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness | ohne Phasenangabe | rekrutiert |
| Effect of Tobacco Heating System (THS) on Closed Lower Limb Fracture Healing | ohne Phasenangabe | rekrutiert |
| Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Med | Phase IV | rekrutiert |
| Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease | — | rekrutiert |
| Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients | Phase II | rekrutiert |
| Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therap | Phase III | rekrutiert |
| Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do N | Phase II | rekrutiert |
| Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) | Phase III | rekrutiert |
| Electrosurgical Intervention Analysis: Comparing Procedure Patterns | — | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry | — | rekrutiert |
| European Disease Registry on Retinopathy of Prematurity (ROP) | — | rekrutiert |
| European Registry of Next Generation Imaging in Advanced Prostate Cancer | — | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell | Phase II | rekrutiert |
| Exercise Training on Brain Insulin Responsiveness | ohne Phasenangabe | rekrutiert |
| Extension Study for the Port Delivery System With Ranibizumab (Portal) | Phase III | rekrutiert |
| Eye Diseases "Treated" With Interoperable Medical Informatics | — | rekrutiert |
| EyeConic: Qualification for Cone-Optogenetics | — | rekrutiert |
| FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer | Phase I | rekrutiert |
| FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene C | Phase I | rekrutiert |
| Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac | ohne Phasenangabe | rekrutiert |
| Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FL | Phase II | rekrutiert |
| First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Effica | Phase I | rekrutiert |
| Fracture Monitor - Femur | ohne Phasenangabe | rekrutiert |
| Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study | — | rekrutiert |
| FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibiti | Phase I | rekrutiert |
| GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological | — | rekrutiert |
| GISAR German Interdisciplinary Sarcoma Registry | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study | — | rekrutiert |
| Genetic Causes of Discrepant Clinic in Monogenic Twins | — | rekrutiert |
| Genome-based Management of Patients in Precision Medicine (Ge-Med) Towards a Genomic Health Prog | ohne Phasenangabe | rekrutiert |
| Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITIO | Phase II | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| German-funded Laparoscopic Approach to Cervical Cancer | ohne Phasenangabe | rekrutiert |
| Gestational Diabetes | — | rekrutiert |
| Global Registry and Natural History Study for Mitochondrial Disorders | — | rekrutiert |
| HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) | Phase III | rekrutiert |
| Hyperthermia With Chemoradiotherapy in Rectal Cancer | ohne Phasenangabe | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better U | ohne Phasenangabe | rekrutiert |
| Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Phase II | rekrutiert |
| Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer | — | rekrutiert |
| Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies | — | rekrutiert |
| Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2 | — | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| Inflammation During ECMO Therapy and ECMO Weaning | ohne Phasenangabe | rekrutiert |
| Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phen | Phase III | rekrutiert |
| Intermittent Fasting to Improve Insulin Secretion | ohne Phasenangabe | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization a | Phase III | rekrutiert |
| Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease ( | Phase I | rekrutiert |
| Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral An | — | rekrutiert |
| Investigation of TVNS Administration on Postpartum Mental Health | ohne Phasenangabe | rekrutiert |
| Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH | Phase III | rekrutiert |
| L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) | Phase II | rekrutiert |
| L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma | Phase II | rekrutiert |
| L19IL2/TNF in Patients With Basal Cell Carcinoma | Phase II | rekrutiert |
| LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated | Phase I / Phase II | rekrutiert |
| LEOPARD Training and Validation Data Collection Study | — | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |
| Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdi | — | rekrutiert |
| Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irrese | ohne Phasenangabe | rekrutiert |
| Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Pha | Phase III | rekrutiert |
| Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells | Phase II / Phase III | rekrutiert |
| Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies | ohne Phasenangabe | rekrutiert |
| Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator | — | rekrutiert |
| Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRA | Phase III | rekrutiert |
| Long-term Follow-up of Children Born in the PETN Studies | — | rekrutiert |
| Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Curr | Phase III | rekrutiert |
| MB-CART19.1 in Refractory SLE | Phase I / Phase II | rekrutiert |
| MED-EL HEARING SOLUTIONS (MEHS): AN OBSERVATIONAL STUDY | — | rekrutiert |
| MELODY Registry Follow-Up Study | — | rekrutiert |
| Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Tri | ohne Phasenangabe | rekrutiert |
| Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Ge | Phase III | rekrutiert |
| Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administere | Phase I / Phase II | rekrutiert |
| Meningioma and Embolism Thrombosis Risk & Investigation of Coagulation | — | rekrutiert |
| MiCLASP Post Market Clinical Follow-Up (PMCF) Study | — | rekrutiert |
| Molecular Inflammation Board at the Center for Personalized Medicine | — | rekrutiert |
| Molecular Tumor Board at the Center for Personalized Medicine Tübingen | — | rekrutiert |
| Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-F | ohne Phasenangabe | rekrutiert |
| Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-orient | ohne Phasenangabe | rekrutiert |
| Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection | — | rekrutiert |
| Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections | Phase III | rekrutiert |
| Natural History of Type 1 Interferonopathies: Insights From a European Cohort | — | rekrutiert |
| Negative Emotionality and Epigenetics During Puberty | — | rekrutiert |
| NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-ne | Phase III | rekrutiert |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HE | Phase II | rekrutiert |
| Neoadjuvant Darovasertib in Primary Uveal Melanoma | Phase III | rekrutiert |
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Ear | Phase II | rekrutiert |
| Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab | Phase II | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| Non Interventional German Leptomeningeal Disease Register | — | rekrutiert |
| Non-Interventional Study on the Prevalence of Cardiac Amyloidosis in Patients With Higher-Grade | — | rekrutiert |
| Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants | — | rekrutiert |
| ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) | Phase III | rekrutiert |
| Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melan | — | rekrutiert |
| Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity | Phase II | rekrutiert |
| Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy | Phase II | rekrutiert |
| Otoferlin Gene-mediated Hearing Loss Natural History Study | — | rekrutiert |
| Oxytocin and Reward Processing in Women | ohne Phasenangabe | rekrutiert |
| PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE | — | rekrutiert |